March 25, 2021
Scientists find evidence that novel coronavirus infects the mouth’s cells
An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth.…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: COVID-19
March 25, 2021
AstraZeneca answers accusation to stockpiling vaccines; 13M doses for COVAX, 16M for Europe
AstraZeneca has denied accusations of stockpiling vaccines stating that the process of manufacturing vaccines is very complex and time consuming…
March 23, 2021
Investigational AstraZeneca vaccine prevents COVID-19
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is…
March 12, 2021
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Conditional Marketing Authorization by European Commission
Data have demonstrated vaccine protects against COVID-19 related hospitalization in broad geographic regions, including those with emerging variants1
Decision follows the European Medicines Agency recommendation of the J&J COVID-19 vaccine2
The…
January 28, 2021
Moderna confirms talking with the US on 100M doses of Cov-19 vaccine
After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.
January 25, 2021
Moderna’s vaccine coming to India
Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.
December 22, 2020
Pfizer and BioNTech got positive opinion for their COVID-19 vaccine in EU
European Commission’s decision on conditional marketing authorization is expected imminently, after the positive CHMP opinion, which will make BNT162b2 if authorized, the first COVID-19 vaccine available in the European Union.
December 19, 2020
Moderna’s COVID-19 vaccine authorized in U.S.
U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.
December 18, 2020
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States
Moderna has received positive recommendation in support of Emergency Use Authorization of its COVID-19 vaccine candidate in USA.
December 18, 2020
European Commission Exercises Option for Additional 80 Million Doses of Moderna’s COVID-19 Vaccine Candidate
Total of 160 million doses ordered by the European Commission to date CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology…